Phillips-Medisize is a leading contract design and manufacturing organization (CDMO) that collaborates with the largest pharmaceutical, medtech, and in vitro diagnostic companies in the world. They specialize in bringing breakthrough ideas and innovative branded products to market, delivering proven, highly engineered solutions that improve the lives of millions of people. Their extensive range of offerings includes autoinjectors, pens, wearable injection pumps, diagnostic tests, electrophysiology technology, continuous glucose monitoring systems, and more.
With a focus on human-centered design and seamless collaboration, Phillips-Medisize has received prestigious awards for their cutting-edge products, such as the SKYTROFA Auto-Injector and the needle-free continuous glucose monitor (CGM) developed in partnership with GlucoModicum. Their Aria smart autoinjector and Envoi pen injector platforms offer powerful, flexible, and scalable solutions for drug delivery, while their manufacturing capabilities and strategic locations, including the new Phillips-Medisize Poland Campus, ensure timely product delivery and job creation.
Generated from the website
